We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MaxCyte, Inc. 15 January 2025 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...
MaxCyte Inc on Monday raised its 2024 revenue guidance above initial expectations, and above the updated guide report ...
MaxCyte, Inc. 13 January 2025 MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results ROCKVILLE, MD, January 13, 2025 - MaxCyte, Inc., (Nasdaq: MXCT;...
ROCKVILLE, Md., Jan. 13, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...
MaxCyte, Inc. 02 January 2025 MaxCyte, Inc. ("MaxCyte" or the "Company") Total Voting Rights ROCKVILLE, MD, January 2, 2025: MaxCyte Inc., (NASDAQ: MXCT; LSE: MXCT), a leading...
MaxCyte, Inc. 31 December 2024 MaxCyte, Inc. ("MaxCyte" or the "Company") Exercise of options and PDMR dealing ROCKVILLE, MD, December 31, 2024: MaxCyte Inc., (NASDAQ: MXCT; LSE:...
MaxCyte, Inc. 23 December 2024 MaxCyte Announces Retirement of Board Member Art Mandell ROCKVILLE, MD, December 23, 2024 - MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading...
ROCKVILLE, Md., Dec. 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...
MaxCyte, Inc. 19 December 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...
MaxCyte, Inc. 18 December 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 21 | 5.80110497238 | 362 | 392 | 351 | 106481 | 376.72380884 | DE |
4 | 60 | 18.5758513932 | 323 | 392 | 314 | 58360 | 362.9457771 | DE |
12 | 92 | 31.6151202749 | 291 | 392 | 256 | 55950 | 307.48856395 | DE |
26 | 13 | 3.51351351351 | 370 | 392 | 256 | 31332 | 306.75781269 | DE |
52 | -29.5 | -7.15151515152 | 412.5 | 415 | 256 | 26858 | 325.48478429 | DE |
156 | -187 | -32.8070175439 | 570 | 645 | 172.5 | 38557 | 395.65139614 | DE |
260 | 261.5 | 215.226337449 | 121.5 | 1230 | 120 | 83765 | 567.96620257 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions